Abstract: A device, comprises a microphone and a communication interface configured to send to a premises automation control core audio input received via the microphone. The premises automation control core is configured to determine, based at least in part on the audio input, a premises automation context associated with the device and send to the device via the communication interface a context data indicating the determined context. The devices also comprises a visual display device, a physical input device, and a processor coupled to the visual display device and the communication interface. The processor is configured to receive the context data and cause the visual display device to provide a visual display associated with the context data.

Abstract: An audio input associated with a human utterance received at the audio input device is received from a respective one of a plurality of audio input devices. Each of the plurality of audio input devices is located in a corresponding physical location within the premises. The audio input is mapped to an intent. An audible verbal response associated with the intent is provided as audio output via a selected one or more of a plurality of audio output devices. Each of the plurality of audio output devices is located in an associated physical location within the premises.

Abstract: A power module is configured to accept power from a cable, wherein the power module may be inserted into a standard wall cavity via a small hole. A processor module coupled to the power module comprises a processor and is configured to accept power from the cable for the processor, wherein the processor module may be inserted into the standard wall cavity via the small hole. A sensor module coupled to the processor module, comprises a sensor and is configured to accept input from the sensor for the processor, wherein the sensor module may be inserted into the small hole.

Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.